You just read:

Aegle Therapeutics Announces $4M Financing to Fund Groundbreaking Stem Cell Exosome Clinical Trial to Treat Orphan Disease Dystrophic Epidermolysis Bullosa

News provided by

Aegle Therapeutics Corp.

Jan 07, 2020, 14:00 ET